STERIS (STE) Revenue & Revenue Breakdown
STERIS Revenue Highlights
Latest Revenue (Y)
$5.14B
Latest Revenue (Q)
$1.28B
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
STERIS Revenue by Period
STERIS Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $5.14B | 3.65% |
| 2023-03-31 | $4.96B | 8.13% |
| 2022-03-31 | $4.59B | 47.55% |
| 2021-03-31 | $3.11B | 2.53% |
| 2020-03-31 | $3.03B | 8.94% |
| 2019-03-31 | $2.78B | 6.19% |
| 2018-03-31 | $2.62B | 0.28% |
| 2017-03-31 | $2.61B | 16.71% |
| 2016-03-31 | $2.24B | 21.00% |
| 2015-03-31 | $1.85B | 14.06% |
| 2014-03-31 | $1.62B | 8.01% |
| 2013-03-31 | $1.50B | 7.93% |
| 2012-03-31 | $1.39B | 15.24% |
| 2011-03-31 | $1.21B | -4.00% |
| 2010-03-31 | $1.26B | -3.14% |
| 2009-03-31 | $1.30B | 2.64% |
| 2008-03-31 | $1.27B | 5.65% |
| 2007-03-31 | $1.20B | 3.20% |
| 2006-03-31 | $1.16B | 3.62% |
| 2005-03-31 | $1.12B | 3.01% |
| 2004-03-31 | $1.09B | 11.82% |
| 2003-03-31 | $972.09M | 12.16% |
| 2002-03-31 | $866.70M | 8.33% |
| 2001-03-31 | $800.09M | 5.19% |
| 2000-03-31 | $760.63M | -4.64% |
| 1999-03-31 | $797.60M | 10.83% |
| 1998-03-31 | $719.66M | 22.41% |
| 1997-03-31 | $587.90M | 544.63% |
| 1996-03-31 | $91.20M | 41.84% |
| 1995-03-31 | $64.30M | 40.39% |
| 1994-03-31 | $45.80M | - |
STERIS generated $5.14B in revenue during NA 2024, up 3.65% compared to the previous quarter, and up 184.70% compared to the same period a year ago.
STERIS Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.28B | -9.86% |
| 2024-03-31 | $1.42B | 1.70% |
| 2023-12-31 | $1.40B | 3.97% |
| 2023-09-30 | $1.34B | 4.50% |
| 2023-06-30 | $1.28B | -7.24% |
| 2023-03-31 | $1.38B | 13.89% |
| 2022-12-31 | $1.22B | 1.29% |
| 2022-09-30 | $1.20B | 3.81% |
| 2022-06-30 | $1.16B | -4.48% |
| 2022-03-31 | $1.21B | 0.14% |
| 2021-12-31 | $1.21B | 1.00% |
| 2021-09-30 | $1.20B | 23.60% |
| 2021-06-30 | $968.42M | 10.86% |
| 2021-03-31 | $873.53M | 7.99% |
| 2020-12-31 | $808.92M | 6.98% |
| 2020-09-30 | $756.13M | 13.04% |
| 2020-06-30 | $668.93M | -18.72% |
| 2020-03-31 | $822.99M | 6.29% |
| 2019-12-31 | $774.26M | 5.08% |
| 2019-09-30 | $736.84M | 5.75% |
| 2019-06-30 | $696.80M | -9.30% |
| 2019-03-31 | $768.21M | 10.34% |
| 2018-12-31 | $696.24M | 2.54% |
| 2018-09-30 | $678.96M | 6.29% |
| 2018-06-30 | $638.76M | -10.78% |
| 2018-03-31 | $715.97M | 8.17% |
| 2017-12-31 | $661.90M | 4.37% |
| 2017-09-30 | $634.16M | 4.31% |
| 2017-06-30 | $607.96M | -10.75% |
| 2017-03-31 | $681.19M | 5.32% |
| 2016-12-31 | $646.77M | 0.06% |
| 2016-09-30 | $646.41M | 1.26% |
| 2016-06-30 | $638.38M | -7.52% |
| 2016-03-31 | $690.28M | 56.92% |
| 2015-12-31 | $439.90M | -10.21% |
| 2015-09-30 | $489.90M | -20.82% |
| 2015-06-30 | $618.69M | 23.33% |
| 2015-03-31 | $501.65M | 21.57% |
| 2014-12-31 | $412.64M | -10.82% |
| 2014-09-30 | $462.73M | -2.22% |
| 2014-06-30 | $473.24M | 1.71% |
| 2014-03-31 | $465.29M | 26.56% |
| 2013-12-31 | $367.65M | -4.20% |
| 2013-09-30 | $383.76M | -5.37% |
| 2013-06-30 | $405.55M | -5.29% |
| 2013-03-31 | $428.22M | 27.08% |
| 2012-12-31 | $336.96M | -5.43% |
| 2012-09-30 | $356.32M | -6.33% |
| 2012-06-30 | $380.40M | -2.52% |
| 2012-03-31 | $390.25M | 22.47% |
| 2011-12-31 | $318.64M | -7.02% |
| 2011-09-30 | $342.71M | -3.52% |
| 2011-06-30 | $355.21M | -5.97% |
| 2011-03-31 | $377.76M | 99.89% |
| 2010-12-31 | $188.98M | -39.51% |
| 2010-09-30 | $312.43M | -4.83% |
| 2010-06-30 | $328.28M | -1.16% |
| 2010-03-31 | $332.13M | 17.14% |
| 2009-12-31 | $283.54M | -9.77% |
| 2009-09-30 | $314.23M | -4.15% |
| 2009-06-30 | $327.83M | -4.80% |
| 2009-03-31 | $344.37M | 10.53% |
| 2008-12-31 | $311.56M | -3.58% |
| 2008-09-30 | $323.13M | 1.15% |
| 2008-06-30 | $319.47M | -14.85% |
| 2008-03-31 | $375.17M | - |
STERIS generated $1.28B in revenue during Q1 2025, up -9.86% compared to the previous quarter, and up 92.39% compared to the same period a year ago.
STERIS Revenue Breakdown
STERIS Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 24 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|---|---|---|---|---|
| Service | $2.37B | $2.03B | $1.66B | $1.63B | $1.49B |
| Product | $2.76B | $2.56B | $1.44B | $1.40B | $1.30B |
STERIS's latest annual revenue breakdown by segment (product or service), as of Mar 24: Product (53.79%), and Service (46.21%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $656.29M | $483.00M | $804.76M | $762.34M | $713.86M | $679.04M | $666.39M | $637.08M | $684.51M | $697.26M | $685.24M | $489.28M | $427.61M | $375.31M | $339.50M | $301.11M | $393.59M | $363.80M | $337.67M | $307.74M |
| Service | $623.21M | $633.15M | $590.89M | $580.02M | $570.68M | $536.95M | $534.12M | $519.41M | $526.18M | $511.71M | $511.75M | $479.14M | $445.92M | $433.61M | $416.63M | $367.82M | $429.40M | $410.47M | $399.17M | $389.07M |
STERIS's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (51.29%), and Service (48.71%).
STERIS Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 24 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|---|---|---|---|---|
| UNITED STATES | $3.75B | $3.23B | $2.23B | $2.21B | $1.98B |
| Other foreign locations | $1.30B | $1.27B | $808.58M | $755.35M | $748.57M |
| IRELAND | $82.69M | $82.01M | $71.91M | $63.82M | - |
| Service | - | $2.03B | - | - | - |
| Product | - | $2.56B | - | - | - |
STERIS's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (73.00%), Other foreign locations (25.39%), and IRELAND (1.61%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $946.89M | $802.56M | $1.03B | $992.88M | $930.54M | $883.39M | $871.98M | $834.10M | $845.83M | $851.29M | $852.50M | $679.25M | $613.48M | $572.40M | $549.45M | $491.71M | $599.97M | $562.50M | $538.10M | $511.15M |
| IRELAND | $22.19M | $22.52M | $19.65M | $20.44M | $20.09M | $17.96M | $17.00M | $18.18M | $19.93M | $20.09M | $20.05M | $21.95M | $20.13M | $20.32M | $17.09M | $14.37M | $17.42M | $16.13M | $15.17M | $15.11M |
| Other foreign locations | $310.42M | $291.07M | $350.54M | $329.04M | $333.92M | $314.64M | $311.54M | $304.21M | $344.93M | $337.59M | $324.44M | $267.23M | $239.92M | $216.21M | $189.59M | $162.85M | $205.61M | $195.63M | $183.57M | $170.54M |
STERIS's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (74.00%), Other foreign locations (24.26%), and IRELAND (1.73%).
STERIS Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SYK | Stryker | $20.50B | $5.42B |
| SNN | Smith & Nephew | $5.55B | $2.79B |
| STE | STERIS | $5.14B | $1.28B |
| BRKR | Bruker | $2.96B | $800.70M |
| MASI | Masimo | $2.05B | $492.80M |
| PODD | Insulet | $1.70B | $488.50M |
| ITGR | Integer | $1.60B | $753.01M |
| CNMD | CONMED | $1.24B | $332.10M |
| LIVN | LivaNova | $1.15B | $318.60M |
| PEN | Penumbra | $1.06B | $299.40M |
| IRTC | iRhythm | $492.68M | $148.05M |
| ZIMV | ZimVie | $457.43M | $116.81M |
| GKOS | Glaukos | $314.71M | $95.69M |
| ANIK | Anika Therapeutics | $166.66M | $41.92M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
STE Revenue FAQ
What is STERIS’s yearly revenue?
STERIS's yearly revenue for 2024 was $5.14B, representing an increase of 3.65% compared to 2023. The company's yearly revenue for 2023 was $4.96B, representing an increase of 8.13% compared to 2022. STE's yearly revenue for 2022 was $4.59B, representing an increase of 47.55% compared to 2021.
What is STERIS’s quarterly revenue?
STERIS's quarterly revenue for Q1 2025 was $1.28B, a -9.86% decrease from the previous quarter (Q4 2024), and a -0.39% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.42B, a 1.70% increase from the previous quarter (Q3 2024), and a 2.49% increase year-over-year (Q4 2023). STE's quarterly revenue for Q3 2024 was $1.4B, a 3.97% increase from the previous quarter (Q2 2024), and a 14.77% increase year-over-year (Q3 2023).
What is STERIS’s revenue growth rate?
STERIS's revenue growth rate for the last 3 years (2022-2024) was 12.07%, and for the last 5 years (2020-2024) was 69.54%.
What are STERIS’s revenue streams?
STERIS's revenue streams in r 24 are Service, and Product. Service generated $2.37B in revenue, accounting 46.21% of the company's total revenue, up 17.05% year-over-year. Product generated $2.76B in revenue, accounting 53.79% of the company's total revenue, up 8.12% year-over-year.
What is STERIS’s main source of revenue?
For the fiscal year ending Mar 24, the largest source of revenue of STERIS was Product. This segment made a revenue of $2.76B, representing 53.79% of the company's total revenue.